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(DAS28)Abstract Aim of the work: To assess the effect of clinical manifestations, disease activity and med-
ications on health-related quality of life (HRQoL) among patients with early rheumatoid arthritis
(RA).
Patients and methods: Twenty-six early RA patients (mean age 43.31 ± 10.51 years, disease dura-
tion: 16.5 ± 5.2 months) diagnosed according to the 2010 RA classiﬁcation criteria were recruited
from the outpatient clinic of the Rheumatology and Rehabilitation Department, Sohag University,
and 22 age and sex matched healthy persons participated in a case control study. Demographic data
were taken from all participants in the study. The 36-item short-form health survey (SF-36) andHam-
iltonAnxietyRating Scale (HAM-A)were assessed asmeasures ofHRQoLandpsychiatric comorbid-
ity for both patients and controls. Disease activity in RA was assessed using the disease activity score
(DAS28). Scoring algorithmswere applied to produce the physical andmental component scores (PCS
andMCS).
Results: There was statistically signiﬁcant difference in the total SF36 score, anxiety and depression
scores of HAM-A scale between patients and controls. The PCS showed the highest signiﬁcant
difference (p< 0.0001), followed by SF36 (p= 0.01) andMCS (p= 0.024). Therewere no signiﬁcant
differences according to the age, gender, occupation or level of education of the patients. Anxiety and
depression scores signiﬁcantly correlatedwith thebodily pain andDAS28 scores and inverselywith the
52 E.M. Abu Al-Fadl et al.PCS and MCS. The DAS28 strongly negatively correlated with the PCS and MCS.
Conclusion: Rheumatoid arthritis has a major impact on many areas of an individual’s life and
tends to have a profound impact on the health-related quality of life.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and
Arthritis.Open access under CC BY-NC-ND license.1. Introduction
Rheumatoid arthritis (RA) is a chronic disabling multisystem
autoimmune disease. It can lead to serious consequences
regarding functional abilities of patients. The physical disabil-
ity caused by RA is usually evident at clinical level; however,
the psychological and social morbidities very easily evade the
eyes of the clinician [1]. Health-related quality of life (HRQoL)
questionnaires for patients are usually used to numerically
quantify the effect of disease morbidity on patient’s daily
living.
HRQoL is important for measuring the impact of the dis-
ease, and for evaluating the effects and cost-effectiveness of
the treatment. Some studies have assessed the HRQoL in pa-
tients with RA and its improvement with early treatment [1–
3]. The medical outcome study with 36-item short-form (SF-
36) is one of the widely used tools that evaluates HRQoL
due to an underlying illness [4].
Monitoring of people’s health at the national level has tra-
ditionally focused on morbidity and mortality measures,
reportable infectious diseases, chronic conditions, and behav-
ioural risk factors. However, these measures do not take in
consideration the HRQoL which provides a broader view of
daily living activity and subjective well being [5,6].
Quality of life is a multi-dimensional concept which is used
to describe the individual’s perceptions, satisfaction, and eval-
uation of different areas of their own lives, such as physical
health and functioning, psychological and emotional well
being, social roles and relationships. The complex, subjective,
and dynamic nature of the concept presents methodological
challenges to its measurement and interpretation [7].
There are no studies from this region assessing the HRQoL
in patients with early RA. The aim of our study was to assess
the effect of clinical manifestations, disease activity and medi-
cations on HRQoL among patients with early RA.2. Patients and methods
Twenty-six early RA patients (8 males and 18 females; mean
age of 43.31 ± 10.51, [range 23–60] years) diagnosed accord-
ing to the American college of Rheumatology (ACR)/Euro-
pean League against rheumatism (EULAR) 2010 RA
classiﬁcation criteria [8] were recruited from the outpatient
clinic of the Rheumatology and Rehabilitation Department,
Sohag University and 22 age and sex matched healthy persons
(4 males and 18 females; mean age of 39.64 ± 9.01 [range 21–
60] years) participated in a case-control study. Patients had
early RA with disease duration of 16.5 ± 5.2 months (ranging
from 3 months up to two years). All patients were >18 years
and gave informed written consent before inclusion in the
study. This study was approved by the local ethics committee
of Sohag Faculty of Medicine.Patients who suffer past or current history of chronic
inﬂammatory diseases (e.g. gout, reactive arthritis, or psoriatic
arthritis), other autoimmune rheumatic diseases (e.g. systemic
lupus erythematosus, mixed connective tissue disease, sclero-
derma, or polymyositis), neuropsychiatric disorders (e.g. ﬁbro-
myalgia) and disease duration of more than 2 years were
excluded from the study.
Demographic data (age, sex, job, marital state and educa-
tion) were taken from all participants in the study. The
short-form SF-36, and Hamilton Anxiety Rating Scale
(HAM-A) were assessed as measures of HRQoL and psychiat-
ric co-morbidity for both patients and controls respectively.
Disease activity in RA patients was assessed using the disease
activity score in 28 joints (DAS28) which included an assess-
ment of the visual analogue scale (VAS) for pain, number of
tender joints (Notj), number of swollen joints (Nosj) and the
erythrocyte sedimentation rate (ESR). Patients with DAS28
score higher than 5.1 were considered to have high disease
activity, whereas a DAS28 below 3.2 indicates low disease
activity. A patient is considered to be in remission if they have
a DAS28 lower than 2.6. Items and scales of SF-36 question-
naire [9] were constructed using the Likert method of sum-
mated ratings. Answers to each question are scored, then
these scores were summed to produce raw scale scores for each
health concept which were then transformed to a 0–100 scale.
Scoring algorithms can then be applied to produce the Physical
Component Score (PCS) and Mental Component Score
(MCS).
The 14 items’ HAM-A was scored from 0 to 4 (no to very
severe or grossly disabling anxiety) on each item of the scale.
The total anxiety score range from 0 to 56. The seven psychic
anxiety items elicit psychic anxiety score that ranges from 0 to
28. The remaining seven items yield somatic anxiety score that
also ranges from 0 to 28. Patients having scores ranging from
15 to 28 were considered to have mild anxiety, those who have
score range from 29 to 42 were considered to have moderate
anxiety, and those who have scores >42 were considered to
have severe anxiety [10–11].
Statistical analysis: Data were analysed and expressed in
tables and ﬁgures as mean values ± standard deviations
(SD). Student’s t-test was used to compare differences between
RA and controls. Pearson correlation test was used to study
correlation between different quantitative variables with each
group. Values were considered signiﬁcant when p-values were
60.05. IBM-SPSS program (version 19) was used for statistical
analyses.
3. Results
Patients and controls were age and sex matched, no signiﬁcant
statistical difference was found (t= 1.28; p= 0.21, and
x2 = 1.01; p= 0.32). All patients had early RA with mean
disease duration of 16.5 ± 5.2 (range 6–24) months.
Table 2 Difference in quality of life scores according to SF 36,
depression and anxiety between rheumatoid arthritis (RA)
patients and controls.
Scores mean ± SD Patients Controls P-Value
Physical health 42.35 18.35 64.19 20.48 <0.0001
Physical functioning 62.12 23.46 79.32 18.15 0.007
Role physical 42.31 37.26 63.64 37.58 0.05
Bodily pain 66.5 27.0 34.5 20.5 0.002
General health 31.92 10.78 62.09 14.58 0.000
Mental health 44.01 20.38 57.88 20.77 0.024
Vitality 34.42 18.18 52.27 23.23 0.005
Social functioning 51.92 27.316 67.682 23.05 0.038
Role emotional 52.56 42.35 49.98 39.51 0.829
Mental health 49.23 15.99 57.27 20.67 NS
TOTAL SF36 score 45.69 20.84 62.01 21.06 0.01
Depression 16.8 7.5 4.05 4.17 0.001
Anxiety 9.35 5.477 5.82 4.895 0.024
SF-36, 36-item short-form.
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tions received by the RA patients are presented in Table 1. The
controls were of comparable education level to the patients;
6(27.2%) were non-educated, 5(22.7%) achieved primary edu-
cation, 4(18%) secondary education and 7(31.8%) highly edu-
cated. However, there were much more employed controls
(86%) and 2 were workers and only one was a housewife.
There was statistically signiﬁcant difference between total
SF36 score, anxiety and depression scores of HAM-A scale be-
tween patients and controls (Table 2). Moreover, all SF36 sub-
scales were signiﬁcantly different between both groups
(Table 2).
The signiﬁcant differences between patients and controls in
all PCS, MCS, total SF-36, depression and anxiety scores were
not related to the sex of the patient (F= 0.67; p= 0.42). Also,
there was no statistically signiﬁcant difference between male
and female patients regarding the VAS, Nosj, Notj, ESR and
DAS28.
Regarding the effect of occupation on HRQoL and psychi-
atric scales, there was no statistically signiﬁcant difference be-
tween employees and housewives in physical functioning,
bodily pain, PCS, MCS, total SF-36, depression and anxiety
scores (F= 0.006, 0.18, 0.63, 0.56, 0.59, 0.102 and 0.302,
respectively; p= 0.94, 0.68, 0.43, 0.46, 0.45, 0.75 and 0.59,Table 1 Demographic and clinical characteristics as well as
the medications received by the rheumatoid arthritis (RA)
patients.
Feature RA patients (n= 26)
Mean ± SD
Age (years) 43.31 ± 10.51
Disease duration (months) 16.5 ± 5.2
Gender F/M 18/8
VAS 8.31 ± 1.85
Notj 4.23 ± 3.42
Nosj 9.19 ± 6.48
ESR (mm/1st hour) 50.31 ± 20.09







Primary educated 3 (11.5)
Secondary educated 7 (26.9)
Highly educated 8 (30.8)
Type of treatment
Not any 2 (7.7)
MTX only 1 (3.8)
MTX+ antimalarial 5 (19.2)
MTX+ SSZ 1 (3.8)
Lef. only 7 (26.9)
Antimalarials only 2 (7.7)
Lef + antimalarial 4 (15.4)
Lef +MTX 4 (15.4)
VAS, visual analogue scale; Notj, number of tender joints; Nosj,
number of swollen joints; ESR, erythrocyte sedimentation rate;
DAS28, disease activity score in 28 joints; MTX, methotrexate;
SSZ, sulfasalazine; Lef, leﬂunomide.respectively); although being worse in housewives showing a
lower physical function and higher bodily pain. According to
the education level, highly educated patients had a lower qual-
ity of life (QoL) than non-educated patients in the domains of
physical function, the PCS and the MCS although they showed
signiﬁcantly less bodily pain than the non-educated.
The PCS has the highest signiﬁcant difference between
cases and controls (p= 0.0001), followed by SF36
(p= 0.01), then MCS (p= 0.024), but non-signiﬁcant differ-
ences regarding bodily pain, physical functioning, depression
and anxiety (p= 0.399, 0.485, 0.209 and 0.585, respectively).
The age of the patient has nothing to do with HRQoL or psy-
chiatric scales, as there was no signiﬁcant difference between
young (<45 years), and old (>45 years) patients regarding
both HRQoL and psychiatric scores.
The prevalence of anxiety in the present study was 26.9%.
Patients with lower level of education had much higher level of
anxiety than highly educated ones.
There was signiﬁcant negative correlation between anxiety
score at one side and PCS and MCS on the other side
(r= 0.38; p< 0.05, and r= 0.34; p< 0.05 respectively).
The same applies for depression score and PCS and MCS
(r= 0.45; p< 0.05, and r= 0.43; p< 0.05, respectively).
There was signiﬁcant correlation between both anxiety and
depression scores with the bodily pain and DAS28 scores (anx-
iety; r= 0.56; p< 0.01, and r= 0.47; p< 0.05, and depres-
sion; r= 0.63; p< 0.001, and r= 0.55; p< 0.01,
respectively) (Fig. 1). Finally, there was a strongly negative
correlation between DAS28 and both PCS and MCS
(r= 0.89; p< 0.001, and r= 0.9; p< 0.001, respectively)
(Fig. 2).
4. Discussion
Rheumatoid Arthritis is a chronic inﬂammatory disease of un-
known aetiology, with an unpredictable course and prognosis.
Thus, it is not surprising that many patients with RA experi-
ence anxiety and helplessness [12]. The intensity of the disease
varies and the individual has to learn to live with pain and
disabilities to a greater or lesser extent as part of his or her life.
Figure 1 Correlation of the disease activity score (DAS28) with the (a) depression and (b) anxiety scores in early rheumatoid arthritis
patients.
Figure 2 Correlation of the disease activity score (DAS28) with the health-related quality of life (HRQoL) scores; (a) physical health,
(b) mental health and (c) the total short form 36 (SF36) score in early rheumatoid arthritis patients.
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other non-medical aspects of life such as social and emotional
functioning and family and peer relationships from the
patient’s point of view [13].
Five dimensions are recommended as a minimum standard
for measuring health: physical health, mental health, everyday
functioning in social and role activities and general perceptions
of wellbeing [14]. The World Health Organisation (WHO) de-
ﬁnes QoL as an individual’s perception of their position in life
in the context of the culture and value systems in which they
live and in relation to their goals, expectations, standards
and concerns [15]. Quality of life can be divided into health-re-
lated (with physical, psychological, social, and spiritual subdo-
mains) and non-health related (with personal, social
interaction, societal, and environmental subdomains). The
objectives of this study were to determine HRQoL and psycho-
logical distress in patients with early RA and assess the effect
of clinical manifestations, disease activity and medications.
In our study we found that HRQoL scores signiﬁcantly de-
creased in patients compared to controls, they are decreased in
all domains of SF 36. The mean PCS and MCS were signiﬁ-
cantly lower in patients than in controls. These results were
in agreement with the study of West and Jonsson [16], which
concluded that RA has negative impacts on patients’ physical,emotional and social functioning early in the disease measured
by the SF-36.
In our study there were signiﬁcant difference in the SF-36
role physical (RP) and social functioning (SF) subscales ob-
served in patients compared to healthy controls, this is consis-
tent with the results of Benitha and Tikly [17] but in contrast
with an Italian study of Rinaldi et al. [18] that showed no dif-
ference in the SF-36 RP and SF subscales between patients and
controls.
As regards the general health (GH) subscale, it was signif-
icantly affected, this is in contrast to Thyberg et al. [19] where
no affection of the GH was detected. Kojima et al. [20] found
that some patients who had a poor physical status could main-
tain a good mental QoL despite pain, fatigue, psychological
distress, and/or low social support. In the current study it
was found that physical health is of the most affected domains
of SF-36 and this is consistent with Salafﬁ et al. [4]. The bodily
pain (BP) is an important factor in determining the QoL in the
early course of the disease [21]. In our study there is highly sig-
niﬁcant increase in BP in patients than in controls which affect
other aspects in their life such as the social aspect and limita-
tion of their physical activity.
In this study we tried to determine other factors affecting
HRQoL besides RA affection as regards age, sex, level of
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ence in the QoL in patients with early rheumatoid, this is in
agreement with Dagﬁnrud et al. [22] and Salafﬁ et al. [4]
who found that the QoL was similar in men and women how-
ever there were sex related differences as women reported low-
er scores than men in role limitations due to physical function
and in general health subscales. These results were in contrast
with West and Jonsson [16]. The women in their study
reported signiﬁcantly better physical functioning (PF) than
men at 24 months. Furthermore, we found no age difference
as regards the QoL which is in agreement with Thyberg
et al. [19] who found no relation with age or sex. On the other
hand, Nu´n˜ez et al. [23] found that younger patients with the
highest socioeconomic level have better QoL.
According to the education level, we found that highly edu-
cated patients have lower QoL than non-educated patients in
the domains of physical function, PCS and MCS although they
showed a signiﬁcant less bodily pain than non-educated. This
was in contrast with Salafﬁ et al. [4] who found that lower lev-
els of formal education have been reported to be a risk factor
for the presence of chronic musculoskeletal pain and physical
function. In our study we found the worst QoL between house-
wives than employees having a lower physical function and
higher bodily pain. This is in consistent with the study of
Habib et al. [24] and in contrast with Allaire et al. [25] who
found a much lower prevalence of household work disability.
In our study, there is a signiﬁcant inverse correlation be-
tween disease activity score (DAS28) and the PCS and MCS
scores, similar results were found in the study of Benitha and
Tikly [17] and also were consistent with the studies of Taylo
et al. [26] and Aggarwal et al. [27] who found a signiﬁcant ef-
fect of disease duration, functional disability and disease activ-
ity on QoL.
Depression in RA is closely associated with pain, work dis-
ability, health service utilisation, poor adherence to treatment
and suicide [28]. Regular mood assessment by rheumatology
clinical staff may serve to improve awareness and early identi-
ﬁcation of depression, and thus timely identiﬁcation and treat-
ment of depression in RA are critical to overall clinical
management [28–29]. Chronic pain and restriction of physical
activity, instability of the disease symptoms and clinical pro-
gression, and ability to predict the prognosis increase the prev-
alence of anxiety in RA cases [30]. In our study we found
highly signiﬁcant increase in depression in patients compared
to the control, this is similar to the study of Smedstad et al.
[31] and Dickens et al. [32] but another study did not ﬁnd this
difference [33]. Our ﬁndings suggest that some of these differ-
ences might be due to methodological problems such as lack of
the use of strict criteria and appropriate controls.
In our study, we found strong correlation between depres-
sion and anxiety on one hand and PCS and MCS on the other
hand, this is in agreement with Covic et al. [34] who found that
physical limitations predict emotional involvement especially
depression, also there is a strong correlation between them
and speciﬁcally the body pain affection.
In our study we found that patients with lower level of edu-
cation had much higher level of anxiety than highly educated
patients. Evers et al. [35] have reported that low educational
level is associated with depression and anxiety in RA cases.
We also found a strong correlation between anxiety and
depression with the disease activity (DAS28) which is in consis-
tent with Scot [36], who established that disease activity has agreat inﬂuence on the joint damage and clinical outcomes. The
prevalence of anxiety in our study was 26.9% which was in
contrast with El-Miedany and El-Rasheed [37] who found that
the prevalence of anxiety was higher than depression.
Our study conﬁrms that depression deserves more attention
in the care of patients with RA. The goal of treatment is to im-
prove the quality of life, concentrating on changing socio-psy-
chological factors rather than simply bodily functions. This is
in accordance with the results of another study [38]. Depres-
sion is a risk factor for non-compliance with medical treatment
in RA and is a risk factor for poor outcome. Such patients
might not be adhering to medical advice [39].
In conclusion, early RA has a major impact on many areas
of an individual’s life and tends to have a profound impact on
the health-related quality of life.
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